@kingkev I am of belief that any time within the next 12
months can see us with a revenue producing deal. Taking into
account clinical completion times and results, these could
accelerate beyond current expectations thus generating decisive
action of big pharma. I think 12 months as a guideline is a
ballpark advisory figure, not a definite one.
Why IMU is a multi multi bagger, page-14979
-
- There are more pages in this discussion • 10,407 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
